The Hippo pathway controls tissue growth and cell fate, whereas pathway deregulation can induce tumors in model organisms and occurs in a broad range of human carcinomas.14 We found that amlexanox treatment could inhibit the IKBKE protein and alter the abundance and phosphorylation status of the Hippo pathway proteins in glioma cells. This evidence concerns the gene IKBKE and carcinoma.